Literature DB >> 21172690

Oscillating field stimulation in the treatment of spinal cord injury.

Beverly C Walters1.   

Abstract

The application of electrical current to injured tissue is known to promote healing. The use of this modality in healing the injured spinal cord to promote neurologic recovery has been introduced as a potential treatment for patients who previously had minimal hope of recovery. In in vitro and in vivo experiments, neural regeneration has been seen to occur, especially when an oscillating field is used. With this modality, an electrical current is applied in which the polarity changes direction on a periodic basis, preventing the "die-back" phenomenon of severed neural pathways. This mechanism of recovery has been demonstrated in several species in which sacrifice has been undertaken and spinal cords examined. In a study of humans, a small number of patients participated in a single phase Ia trial in which the safety of an implantable device was demonstrated, with indications of probable benefit, consistent with laboratory and animal studies. In addition, a number of additional patients were treated, and their results were examined along with the original cohort and were compared with historical control subjects. The device used in this mode of treatment has not been approved for use in the general spinal cord-injured population, pending further study. A larger multi-institutional trial needs to be done to further demonstrate efficacy and effectiveness, and outcomes will need to be agreed upon by spinal cord injury researchers, patients, and regulators before widespread use will be permitted. Unfortunately, some subtle changes experienced and valued by patients are not recognized as important or desirable by regulators or by all researchers.
Copyright © 2010 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21172690     DOI: 10.1016/j.pmrj.2010.10.014

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  8 in total

Review 1.  Spinal Cord Stimulation for Pain Treatment After Spinal Cord Injury.

Authors:  Qian Huang; Wanru Duan; Eellan Sivanesan; Shuguang Liu; Fei Yang; Zhiyong Chen; Neil C Ford; Xueming Chen; Yun Guan
Journal:  Neurosci Bull       Date:  2018-12-17       Impact factor: 5.203

Review 2.  Evaluation and Management of SCI-Associated Pain.

Authors:  Michael Saulino; Justin F Averna
Journal:  Curr Pain Headache Rep       Date:  2016-09

3.  Electrical Stimulation as a Tool to Promote Plasticity of the Injured Spinal Cord.

Authors:  Andrew S Jack; Caitlin Hurd; John Martin; Karim Fouad
Journal:  J Neurotrauma       Date:  2020-07-08       Impact factor: 5.269

Review 4.  Endogenous voltage gradients as mediators of cell-cell communication: strategies for investigating bioelectrical signals during pattern formation.

Authors:  Dany S Adams; Michael Levin
Journal:  Cell Tissue Res       Date:  2012-02-17       Impact factor: 5.249

5.  Epidural oscillating field stimulation increases axonal regenerative capacity and myelination after spinal cord trauma.

Authors:  Maria Bacova; Katarina Bimbova; Alexandra Kisucka; Nadezda Lukacova; Jan Galik
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

Review 6.  Management of Acute Traumatic Spinal Cord Injury: A Review of the Literature.

Authors:  Timothy Y Wang; Christine Park; Hanci Zhang; Shervin Rahimpour; Kelly R Murphy; C Rory Goodwin; Isaac O Karikari; Khoi D Than; Christopher I Shaffrey; Norah Foster; Muhammad M Abd-El-Barr
Journal:  Front Surg       Date:  2021-12-13

7.  HEAVEN: The head anastomosis venture Project outline for the first human head transplantation with spinal linkage (GEMINI).

Authors:  Sergio Canavero
Journal:  Surg Neurol Int       Date:  2013-06-13

8.  Electrical stimulation modulates injury potentials in rats after spinal cord injury.

Authors:  Guanghao Zhang; Xiaolin Huo; Aihua Wang; Changzhe Wu; Cheng Zhang; Jinzhu Bai
Journal:  Neural Regen Res       Date:  2013-09-25       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.